default author photo

Eric R. Siegel

University of Arkansas for Medical Sciences - Department of Biostatistics

SCHOLARLY PAPERS

5

DOWNLOADS

285

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

A Gene Signature Can Predict Risk of MGUS Progressing to Multiple Myeloma

Number of pages: 14 Posted: 05 May 2023
Fumou Sun, Yan Cheng, Jun Ying, David Mery, Samer Al Hadidi, Visanu Wanchai, Eric R. Siegel, Hongwei Xu, Dongzheng Gai, Timothy Cody Ashby, Clyde Bailey, Jin-Ran Chen, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Siegfried Janz, Bart Barlogie, Frits van Rhee, Guido Tricot, John D. Shaughnessy and Fenghuang Zhan
University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Department of Biostatistics, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Department of Biostatistics, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Department of Biomedical Informatics, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, Medical College of Wisconsin - Division of Hematology/Oncology, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center, University of Arkansas for Medical Sciences - Myeloma Center and University of Arkansas for Medical Sciences - Myeloma Center
Downloads 91

Abstract:

Loading...

Monoclonal gammopathy of undetermined significance, MGUS, Multiple myeloma, prediction, Gene expression profiling.

2.

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer

Number of pages: 30 Posted: 05 Jan 2026
Alessandro D. Santin, Dana Marie Roque, Eric R. Siegel and See PDF
Yale University - School of Medicine, University of Maryland, Baltimore (UMB), University of Arkansas for Medical Sciences - Department of Biostatistics and Please see PDF for full list of authors & affiliations
Downloads 88

Abstract:

Loading...

sacituzumab govitecan, uterine cancer, endometrial cancer, Trop-2, uterine serous carcinoma, carcinossarcoma

3.

A Phase 2 Trial of Pembrolizumab for Recurrent Lynch-Like Versus Sporadic Endometrial Cancers with Microsatellite Instability (Nct02899793): Updated Survival and Response Analyses

Number of pages: 16 Posted: 06 Mar 2025
Victoria M. Ettorre, Stefania Bellone, Michelle Greenman, Blair McNamara, Luca Palmieri, Namrata Sethi, Cem Demirkiran, Katyayani Papatla, Aparna Kailasam, Eric R. Siegel, Elena Ratner and Alessandro D. Santin
Yale University - School of Medicine, Yale University - School of Medicine, Yale University - School of Medicine, Yale University - School of Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Yale University - School of Medicine, Yale University - School of Medicine, Yale University - School of Medicine, Mayo Clinic, University of Arkansas for Medical Sciences - Department of Biostatistics, Yale University - School of Medicine and Yale University - School of Medicine
Downloads 49

Abstract:

Loading...

Lynch-like MSI-H tumors, endometrial cancer, clinical trial results, immunotherapy, anti-PD1 checkpoint blockade, phase 2 clinical trial

4.

Fetal Magnetoencephalographic Power Spectral Density and Neurobehavioral Correlation in Intrauterine Growth Restriction (IUGR)

Number of pages: 22 Posted: 16 Apr 2026
Ankita Shukla, Vikas Chowdhary, Brooke Yancey-Ward, Natalli Heller, Dannis Armikarina, Alexa Escapita, Luis Mercado, Eric R. Siegel, Richard Hall, Mario Schootman, Sherry Courtney and Hari Eswaran
University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences - Department of Biostatistics, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System
Downloads 34

Abstract:

Loading...

Infant, Fetal growth restriction, Magnetoencephalography, Cognition, Attention

5.

Increased Response to Immune Checkpoint Inhibitors with Dietary Methionine Restriction

Number of pages: 31 Posted: 23 Jan 2023
Lauren C. Morehead, Sarita Garg, Katherine F. Wallis, Eric R. Siegel, Alan J. Tackett and Isabelle R. Miousse
University of Arkansas for Medical Sciences - Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences - Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences - Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences - Department of Biostatistics, University of Arkansas for Medical Sciences - Department of Biochemistry and Molecular Biology and University of Arkansas for Medical Sciences - Department of Biochemistry and Molecular Biology
Downloads 23

Abstract:

Loading...

Methionine, immune checkpoints, colorectal cancer, PD-L1, cGAS-STING